Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-24-025895

Chief Commercial Officer sold 7,852 shares at an average $49.79 ($390,918)

  • Chief Commercial Officer acquired 6,250 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Wise John Drayton · Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-28 Sale : show line 1 in the form 10b5-1 −1,602 $48.95 $78,418 121,657 D
2024-05-28 Exercise or conversion : show line 2 in the form 10b5-1 +6,250 $12.58 $78,625 127,907 D
2024-05-28 Sale : show line 3 in the form 10b5-1 −6,250 $50.00 $312,500 121,657 D
Open-market sales · 7,852 sh · avg $49.79 · $390,918

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-28 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) −6,250 0 D
Loading xslF345X05/wk-form4_1717105566.xml…